Shares of WeightWatchers (WW) are climbing after the company announced a compounded GLP-1 medication starting at $129 as it ...

Shares of WeightWatchers (WW) are climbing after the company announced a new GLP-1 medication starting at $129 as it seeks to ...

The new offering, starting at $129, enhances the Company’s holistic weight management program, which includes behavioral and clinical solutions with support from board-certified clinicians, registered ...

With the addition of compounded semaglutide [GLP-1], we are expanding our offering to include a clinical weight management ...

WeightWatchers (WW) announced Tuesday that it is now offering off-brand weight loss drugs for one of the cheapest prices in ...

WW International ( NASDAQ: WW ), more commonly known as WeightWatchers, will now offer compounded semaglutide to its ...

WeightWatchers will begin selling compounded alternatives to certain weight-loss drugs that are experiencing shortages. Why ...

Shares of WW International, better known as WeightWatchers, soared Tuesday after it said it is offering copycat weight-loss drugs to its members.

WeightWatchers said on Tuesday it would offer compounded form of Novo Nordisk's popular obesity drug Wegovy as part of its ...

Fueled by the rise of the blockbuster GLP-1 drugs, including Ozempic and Wegovy, thinness appears to be making a comeback in ...